
India News
Oct 25•5 min read
Cancer Immunotherapy Costs Drop in India via Biosimilars
Cheaper nivolumab copies and low-dose clinical protocols expand oncology care across Indian hospitals, though distribution hurdles persist.
Verified
1Read Story
1 verified news reports matched your query